Implant derived from bone
View Patent ↗An implant which is particularly suitable for the repair and/or replacement of a skeletal joint, e.g., a vertebral joint, includes a unit of monolithic bone possessing at least one demineralized region exhibiting properties of flexibility and resilience, the demineralized region having diminished or insignificant capacity for promoting new bone growth.
1. An implant which comprises a unit of monolithic bone, wherein the bone is partially demineralized over substantially the entirety of each of its surfaces, such that substantially no portion of the surface is non-demineralized, wherein at least one region of the bone exhibits properties of flexibility and resilience, and wherein at least one region of the bone has diminished or insignificant capacity for promoting new bone growth.
2. The implant of claim 1 wherein the monolithic bone is derived from allogeneic or xenogeneic bone.
3. The implant of claim 1 wherein the monolithic bone is derived from a single piece or section of bone.
4. The implant of claim 3 which is partially and uniformly demineralized.
5. The implant of claim 1 wherein the monolithic bone is assembled from two or more bone pieces or sections.
6. The implant of claim 5 which is partially and uniformly demineralized.
7. The implant of claim 1 which is partially and uniformly demineralized.
8. The implant of claim 1 wherein at least the surface of the demineralized unit of bone lacks any significant quantity of biologically active bone growth-promoting substances.
9. The implant of claim 1 wherein the monolithic bone is derived from the diaphysis of a long bone.
10. The implant of claim 9 configured as an intervertebral disc.
11. The implant of claim 9 wherein the cavity of the intervertebral disc is filled at least in part with a gel-forming polymer or gel derived therefrom.
12. The implant of claim 1 containing at least one substance which enhances fibrous tissue growth.
13. The implant of claim 12 wherein the substance which enhances fibrous tissue growth is acellular dermal tissue and/or small intestine mucosa.
14. The implant of claim 1 containing at least one medically/surgically useful substance.
15. The implant of claim 14 wherein the medically/surgically useful substance is at least one member of the group consisting of collagen, insoluble collagen derivative, antiviral agent, antimicrobial agent, antibiotic, biocidal/biostatic sugar, amino acid, peptide, vitamin, inorganic element, co-factor for protein synthesis, hormone, endocrine tissue or tissue fragment, synthesizer, enzyme, peptidase, oxidase, polymer drug carrier, collagen lattice, antigenic agent, cartilage fragment, living cells, natural extract, modified living cell, tissue transplant, DNA, autogenous tissue, bioadhesive, fibronectin, transforming growth factor-beta, endothelial cell growth factor, cementum attachment extract, ketaserin, insulin-like growth factor, platelet derived growth factor, epidermal growth factor, interleukin, human alphathrombin, fibroblast growth factor, bone digester, antitumor gent, immuno-suppressant, permeation enhancer, and nucleic acid.
16. The implant of claim 1 possessing a bulk density of at least about 0.7 g/cm 3 and a wet compressive strength of at least about 3 MPa.
17. The implant of claim 16 configured as an intervertebral disc.
18. The implant of claim 17 possessing a cavity filled at least in part with a gel-forming polymer or gel derived therefrom.
19. A method of making an implant which comprises:
(a) providing a unit of monolithic bone;
(b) partially demineralizing the entire bone wherein the bone is partially demineralized over substantially the entirety of each of its surfaces, such that substantially no portion of the surface is non-demineralized;
(c) treating the bone to suppress, diminish, or eliminate the capacity for promoting new growth; and
(d) partially or full configuring the monolithic bone to a predetermined implant shape following step (a), (b), or (c).
20. The method of claim 19 wherein the monolithic bone is derived from allogeneic or xenogeneic bone.
21. The method of claim 19 wherein the monolithic bone is derived from a single piece or section of bone.
22. The method of claim 21 wherein demineralizing step (b) provides a partially and uniformly demineralized monolithic bone unit.
23. The method of claim 19 wherein the monolithic bone is assembled from two or more bone pieces or sections.
24. The method of claim 23 wherein demineralizing step (b) provides a partially and uniformly demineralized monolithic bone unit.
25. The method of claim 19 wherein demineralizing step (b) provides a partially and uniformly demineralized monolithic bone unit.
26. The method of claim 19 wherein the monolithic bone is derived from the diaphysis of a long bone.
27. The method of claim 26 wherein configuring step (d) provides an intervertebral disc.
28. The method of claim 19 wherein treating step (c) utilizes a chemical agent which denatures proteins in the demineralized bone which promote bone growth.
29. The method of claim 28 wherein treating step (c) utilizes a chemical agent which additionally crosslinks collagen fibers present in the demineralized bone.
30. The method of claim 29 wherein the chemical agent is glutaraldyhyde.
31. The method of claim 19 wherein treating step (c) utilizes heat of sufficient intensity and duration to denature proteins in the demineralized bone which promote bone growth.
32. The method of claim 19 wherein treating step (c) utilizes an extractant to remove proteins from the demineralized bone which promote bone growth.
33. The method of claim 19 , wherein treating the bone comprises subjecting the bone to high energy irradiation.
34. The method of claim 33 wherein the high energy irradiation occurs in a controlled environment comprising oxygen.
35. An implant which comprises a unit of monolithic bone, wherein the bone is at least partially demineralized over substantially the entirety of each of its surfaces, such that substantially no portion of the surface is non-demineralized, wherein at least one region of the bone exhibits properties of flexibility and resilience, wherein at least one region of the bone has diminished or insignificant capacity for promoting new bone growth, and wherein substantially no portion of the implant is plasticized.
36. The implant of claim 35 wherein the monolithic bone is derived from a single piece or section of bone.
37. The implant of claim 35 wherein the monolithic bone is assembled from two or more bone pieces or sections.
38. The implant of claim 35 wherein the implant is uniformly demineralized.
39. The implant of claim 35 wherein the implant is configured as an intervertebral disc.
40. The implant of claim 35 further comprising at least one substance which enhances fibrous tissue growth.
41. The implant of claim 40 wherein the substance which enhances fibrous tissue growth is acellular dermal tissue and/or small intestine mucosa.